2012;17:250-9. Varga A, Piha-Paul SA, Ott PA, et al. Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1positive advanced ovarian cancer: Interim results from a phase Ib study. J Clin Oncol. 2015; 33(15-suppl); Abstr. # 5510. Wagner KD, Cherfils-Vicini J, Hosen N, et al. The Wilms' tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression. Nat Commun.